MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma

M Ito, K Teshima, S Ikeda, A Kitadate… - Blood, The Journal …, 2014 - ashpublications.org
M Ito, K Teshima, S Ikeda, A Kitadate, A Watanabe, M Nara, J Yamashita, K Ohshima…
Blood, The Journal of the American Society of Hematology, 2014ashpublications.org
In this study, we show that microRNA-150 (miR-150) is significantly downregulated in
advanced cutaneous T-cell lymphoma (CTCL), and that this downregulation is strongly
associated with tumor invasion/metastasis. Inoculation of CTCL cell lines into nonobese
diabetic/Shi-scid interleukin 2γ (IL-2γ) null mice led to CTCL cell migration to multiple
organs; however, prior transfection of the cells with miR-150 substantially reduced the
invasion/metastasis by directly downregulating CCR6, a specific receptor for the chemokine …
Abstract
In this study, we show that microRNA-150 (miR-150) is significantly downregulated in advanced cutaneous T-cell lymphoma (CTCL), and that this downregulation is strongly associated with tumor invasion/metastasis. Inoculation of CTCL cell lines into nonobese diabetic/Shi-scid interleukin 2γ (IL-2γ) null mice led to CTCL cell migration to multiple organs; however, prior transfection of the cells with miR-150 substantially reduced the invasion/metastasis by directly downregulating CCR6, a specific receptor for the chemokine CCL20. We also found that IL-22 and its specific receptor subunit, IL22RA1, were aberrantly overexpressed in advanced CTCL, and that production of IL-22 and CCL20 was increased in cultured CTCL cells. IL22RA1 knockdown specifically reduced CCL20 production in CTCL cells, suggesting that IL-22 upregulation may activate the production of CCL20 and its binding to CCR6, thereby enhancing the multidirectional migration potential of CTCL cells. CTCL cells also exhibited nutrition- and CCL20-dependent chemotaxis, which were inhibited by miR-150 transfection or CCR6 knockdown. From these findings, we conclude that, in the presence of continuous CCR6 upregulation accompanied by miR-150 downregulation, IL-22 activation leads to continuous CCL20-CCR6 interaction in CTCL cells and, in turn, autocrine metastasis to distal organs. This suggests miR-150, CCL20, and CCR6 could be key targets for the treatment of advanced CTCL.
ashpublications.org